Patent 11967292 was granted and assigned to Tandem Diabetes Care on April, 2024 by the United States Patent and Trademark Office.
An apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a color display. Color on the display can be used to bring a user's attention to a change in status of the device or a detected change in status of the patient.